tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
LENZ Therapeutics: Positioned for Growth with Strategic Global Expansion and Imminent FDA Approval
PremiumRatingsLENZ Therapeutics: Positioned for Growth with Strategic Global Expansion and Imminent FDA Approval
2M ago
Lenz Therapeutics reports Q2 EPS (53c), consensus (54c)
Premium
The Fly
Lenz Therapeutics reports Q2 EPS (53c), consensus (54c)
2M ago
Lenz announces CORXEL submitted NDA for LNZ100 in China
Premium
The Fly
Lenz announces CORXEL submitted NDA for LNZ100 in China
2M ago
Lenz Therapeutics’ Earnings Call Highlights Strong Outlook
PremiumCompany AnnouncementsLenz Therapeutics’ Earnings Call Highlights Strong Outlook
4M ago
Lenz Therapeutics, Lotus enter license, commercialization agreement for LNZ100
Premium
The Fly
Lenz Therapeutics, Lotus enter license, commercialization agreement for LNZ100
4M ago
LENZ Therapeutics Positioned for Success with LNZ100 Ahead of 2025 PDUFA Date
Premium
Ratings
LENZ Therapeutics Positioned for Success with LNZ100 Ahead of 2025 PDUFA Date
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100